CFDE Data Portal | Search STAT3

	Label	Description
	STAT3 Gene (Entity type)	ENSG00000168610 - signal transducer and activator of transcription 3
	GSE220283 STAT3 knockdown Hep-G2 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE220283 STAT3 knockdown Hep-G2 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	NFIC Gene (Entity type)	ENSG00000141905 - nuclear factor I C
	VWA1 Gene (Entity type)	ENSG00000179403 - von Willebrand factor A domain containing 1
	GSE240439 decitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE145990 1 V 0 IBRUTINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE220806 progesterone fibroblast 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 5 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

STAT3

ENSG00000168610 - signal transducer and activator of transcription 3

GSE220283 STAT3 knockdown Hep-G2 0 v 1 human up

A Gene Set from LINCS

GSE220283 STAT3 knockdown Hep-G2 0 v 1 human dn

A Gene Set from LINCS

NFIC

ENSG00000141905 - nuclear factor I C

VWA1

ENSG00000179403 - von Willebrand factor A domain containing 1

GSE240439 decitabine 1 v 2 human up

A Gene Set from LINCS

GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN

A Gene Set from LINCS

GSE145990 1 V 0 IBRUTINIB HUMAN UP

A Gene Set from LINCS

GSE220806 progesterone fibroblast 1 v 3 human dn

A Gene Set from LINCS

GSE172016 2 V 5 PACLITAXEL HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.